Abstract
To test the hypothesis that induction of endogenous bFGF can lead to angiogenesis in ischaemic skeletal muscle, we studied the expression of bFGF after transposition of a well-vascularized muscle flap onto an ischaemic hindlimb in the rabbit. The results indicated a marked induction of bFGF mRNA throughout the myoblasts of the well-perfused muscle flap but not the myoblasts of the ischaemic muscle. bFGF protein was detected in the muscle flap, particularly in the myoblasts located closest to a newly formed, adjacent interface, and in the interface itself. In contrast, bFGF expression was not induced after transposition of a well-perfused muscle flap onto healthy muscle tissue. These data provide evidence that the juxtaposition of ischaemic skeletal muscle with healthy mesenchymal tissue triggers an increased expression of bFGF in the myoblasts of the well-perfused muscle. This paracrine induction of bFGF, in turn, leads to increased angiogenesis and regeneration of the ischaemic skeletal muscle.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Folkman, J. & Klagsbrun, M. Angiogenic factors. Science 235, 442–447 (1987).
Gospodarowicz, D., Neufeld, G. & Schweigerer, L. Molecular and biological characterization of fibroblast growth factor, an angiogenic factor which also controls the proliferation and differentiation of mesoderm and neuroectoderm derived cells. Cell Differ. 19, 1–17 (1986).
Gospodarowicz, D. Expression and control of vascular endothelial cells: Proliferation and differentiation by fibroblasts growth factors. J. invest. Dermatol. 93, 39–47 (1989).
Montesano, R., Vassalli, J-D., Baird, A., Guillemin, R. & Orci, L. Basic fibroblast growth factor induces angiogenesis in vitro . Proc. natn. Acad. Sci. U.S.A. 83, 7297–7301 (1986).
Thompson, J.A. et al. Site-directed neovessel formation in vivo . Science 241, 1349–1352 (1988).
Chleboun, J.O., Martins, R.N., Mitchell, C.A. & Chirila, T.V. bFGF enhances the development of the collateral circulation after acute arterial occlusion. Biochem. biophys. Res. Comm. 185, 510–516 (1992).
Yanagisawa-Miwa, A. et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257, 1401–1403 (1992).
Hendricks, D.L. et al. A model of persistent partial hindlimb ischemia in the rabbit. J. Surg. Res. 49, 453–457 (1990).
Pevec, W.C. et al. Revascularization of an ischemic limb by use of a muscle pedicle flap: A rabbit model. J. vasc. Surg. 13, 385–390 (1991).
Baffour, R. et al. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose-response effect of basic fibroblast growth factor. J. vasc. Surg. 16, 181–191 (1992).
Pu, L-Q. et al. A persistent hindlimb ischemia model in the rabbit. J. invest. Surg. 7, 49–60 (1994).
Vignovich, J. & Becker, D. Expression of bFGF and differential expression of FGF receptors in normal human myoblasts and rhabdomyosarcomas. Int. J. Oncol. 2, 637–642 (1993).
Johnson, D.E., Lee, P.L., Lu, J. & Williams, L.T. Diverse forms of a receptor for acidic and basic fibroblast growth factors. Molec. Cell. Biol. 10, 4728–4736 (1990).
Pierce, G.F. et al. Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J. Cell Biol. 109, 429–440 (1989).
Grotendorst, G.R., Martin, G.R., Pencev, D., Sodek, J. & Harvey, A.K. Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats. J. clin. Invest. 76, 2323–2329 (1985).
Plate, K.H., Breier, G., Weich, H.A. & Risau, W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo . Nature 359, 845–848 (1992).
Shweiki, D., Itin, A., Softer, D. & Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843–845 (1992).
Parums, D.V. et al. JC70: A new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J. clin. Pathol. 43, 752–757 (1990).
Nickoloff, B.J. PECAM-1 (CD31) is expressed on proliferating endothelial cells, stromal spindle-shaped cells, and dermal dendrocytes in Kaposi's sarcoma. Arch. Dermatol. 129, 250–251 (1993).
Folkman, J., Haudenschild, C.C. and Zetter, B.R. Long-term culture of capillary endothelial cells. Proc. natn. Acad. Sci. U.S.A. 76, 5217–5221 (1979).
Becker, D., Lee, P.L., Rodeck, U. & Herlyn, M. Inhibition of the fibroblast growth factor receptor 1 (FGFR-1) gene in human melanocytes and malignant melanomas leads to inhibition of proliferation and signs indicative of differentiation. Oncogene 7, 2303–2313 (1992).
Alonso, S., Minty, A., Bourlet, Y. & Buckingham, M. Comparison of three actin-coding sequences in the mouse; evolutionary relationships between the actin genes of warm-blooded animals. J. molec. Evol. 23, 11–22 (1986).
Abraham, J.A. et al. Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science 233, 545–548 (1986).
Nakajima-Iijima, S., Hamada, H., Reddy, P. & Kakunaga, T. Molecular structure of the human cytoplasmic beta-actin gene. Proc. natn. Acad. Sci. U.S.A. 82, 6133–6137 (1985).
Becker, D. & Sahin, A.A. Loss of heterozygosity at chromosomal regions 3p and 13q in non-small cell carcinoma of the lung represents low frequency events. Genomics 4, 97–100 (1989).
Abraham, J.A. et al. Human basic fibroblast growth factor: nucleotide sequence and genomic organization. EMBO J. 5, 2523–2528 (1986).
Wilcox, J.N., Smith, K.M., Williams, L.T., Schwartz, S.M. & Gordon, D. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J. clin. Invest. 82, 1134–1143 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Walgenbach, K., Gratas, C., Shestak, K. et al. Ischaemia-induced expression of bFGF in normal skeletal muscle: A potential paracrine mechanism for mediating angiogenesis in ischaemic skeletal muscle. Nat Med 1, 453–459 (1995). https://doi.org/10.1038/nm0595-453
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0595-453
This article is cited by
-
Vakuumtherapie und Defektdeckung beim Weichteiltrauma
Der Unfallchirurg (2007)
-
Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia
Gene Therapy (2001)
-
Angiogenesis induced in muscle by a recombinant adenovirus expressing functional isoforms of basic fibroblast growth factor
Gene Therapy (1999)
-
Angiogenic growth factor release system for in vivo tissue engineering: a trial of bone marrow transplantation into ischemic myocardium
Journal of Artificial Organs (1999)